An unexplained death at a Russian plague research institute has prompted international scrutiny. The incident raises questions about laboratory safety, transparent reporting, and infection prevention preparedness while the cause remains unconfirmed.
News|Articles|October 10, 2012
Researcher Wins Innovation Award for Vaccine for the Prevention of Staph Infection
Advertisement
Boise State University researcher Juliette Tinker, associate professor of biological sciences, has been named the winner of an Idaho Innovation Award for her research on a vaccine for the prevention of staph and MRSA infection in humans and dairy cows.
Tinker won in the Early-stage Innovation of the Year category. Winners and finalists were recognized during the Idaho Technology Councils third annual Hall of Fame Celebration on Oct. 2.
Being named an Idaho Innovation Awards finalist or winner symbolizes an unbiased endorsement by our communitys business leaders, says Jason Prince, Stoel Rives attorney and 2012 Idaho Innovation Awards co-chairman. The nominations were judged by a selection committee consisting of almost 30 leaders from Idahos business, technology and academic communities.
Antibiotic-resistant staph and MRSA infections in humans and animals are caused by the bacterium Staphylococcus aureus (S. aureus). Findings by the Centers for Disease Control and Prevention (CDC) suggest that S. aureus and MRSA should be considered a national priority for disease control.
Tinkers novel vaccine offers a preventative solution to the current post-infection long-term treatment for the infections. Major advantages include economic improvements for agricultural animals and livestock and improvements in the quality of life for animal and human inoculated populations.
To date, the invention has one patent pending in the United States. The innovation is unique because it is the only preventative vaccine candidate for S. aureus and MRSA that can be delivered to the nose, mouth or skin to prevent mucosal colonization.
Tinker is an associate professor in the Department of Biological Sciences. She joined Boise State in 2005.
The Idaho Innovation Awards are presented by the Stoel Rives law firm, Kickstand and the Idaho Technology Council, and are supported by Idaho TechConnect and the Cooper Norman accounting firm.
Source: Boise State University
Also see:
Advertisement
Related to this article
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.
This week's coverage in Infection Control Today centered on a common thread: the systems, partnerships, and data that let infection prevention teams catch problems before patients are harmed.
UPMC’s genomic surveillance initiative earned national recognition for patient safety. Alexander Sundermann, DrPH, CIC, FAPIC, AL-CIP, explains how the award could help infection preventionists secure leadership support and sustainable funding for earlier outbreak detection.
Knowing the protocol is only the beginning. In The Clean Bite, Sherrie Busby explores how explaining the why, addressing staff concerns, and creating clear procedures can help dental teams make infection control part of everyday practice.
What might infection prevention rounds miss when visible conditions dominate the conversation? Tommy Davis, PhD, CMIP, a member of ICT's executive advisory board, makes the case for structured observations of clinical workflows, shared accountability, and greater attention to environmental services staff’s insights.
A proposed $27.7 million reduction in AHRQ funding raises questions about support for infection prevention research and implementation. Here is what the September 25 announcement identifies, as well as what remains unknown about specific IPC programs.
Advertisement
Advertisement